Instrument Inactif

Autres langues Hospira, Inc.

Actions

US4410601003

Produits pharmaceutiques

Cours en clôture NYSE Autres places de cotation
- ^USD	-

28/08/15	Activision Blizzard et United Continental intègrent le S&P-500	RE
24/08/15	Apple : Les valeurs à suivre à Wall Street	RE

Autres langues

27/08/15	Hospira : Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™
27/08/15	Hospira : Announces First Installation of Plum 360(TM) Infusion System With Hospira MedNet(TM)
21/08/15	Hospira : Expert committee BACKS Hospira’s InflectraTM
20/08/15	Hospira : Charleston Area Medical Center Integrates Smart Pump Technology to Advance Patient Safety
20/08/15	Hospira : TGA Approves First mAb Biosimilar
13/08/15	Hospira : Applauds UK's NICE for Issuing Adoption Resource to Help Drive the Introduction of Biosimilars
04/08/15	Hospira : Pfizer wins EU approval for $15 billion Hospira buy
28/07/15	Allergan : Mylan independence from Teva's embrace comes with a price
16/07/15	Hospira : Announces U.S. Launch of Generic Bivalirudin for Injection
15/07/15	Hospira : to Announce Second-Quarter 2015 Results on July 29, 2015
14/07/15	Hospira : Pfizer offers concessions in bid to win EU okay for Hospira deal
03/07/15	Celltrion : Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
10/06/15	Hospira : New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra™ (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade™
10/06/15	Hospira : New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra(TM) (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade(TM)
02/06/15	Hospira : ANVISA Approves First Infliximab Biosimilar in Brazil
20/05/15	Hospira : Alliance for Health Reform Bring Food and Drug Administration, Industry Experts Together to Discuss the Future of Biosimilars in the United States
13/05/15	Hospira : Shareholders Approve Merger of Hospira and Pfizer at Special Meeting
06/05/15	Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal
01/05/15	Hospira : Statement On FDA's Final Biosimilar Guidance Documents
24/04/15	Hospira : Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation
14/04/15	AbbVie : Banks see talent flee amid healthcare M&A boom
13/04/15	Hospira : Hope for Greater Access for Patients to Biosimilar Medicines
08/04/15	Actavis : Generic drugmaker Mylan offers $29 billion for Perrigo
07/04/15	Hospira : to Announce First-Quarter 2015 Results on April 28, 2015
30/03/15	Hospira : INFLECTRA(TM) (Infliximab) Now Available in Canada